• HOME
  • Search & Results
  • Full Text
  • Thesis Details
 
Page: 164
 
Full Screen

  • TITLE
  • CERTIFICATE-1
  • CERTIFICATE-2
  • DECLARATION
  • ACKNOWLEDGEMENT
  • TABLE OF CONTENTS
  • ABBREVIATIONS
  • 1. Introduction and review of related literature
  • 1.1 Introduction
  • 1.2 Review of related literature
  • 1.2.1 The liver - its structure and function
  • 1.2.1.a. The structure of liver
  • 1.2.1.b Liver functions
  • 1.2.2 Liver disorders caused by drugs and toxins
  • 1.2.3 Hepatic drug metabolism
  • 1.2.4 Carbon tetrachloride toxicity
  • 1.2.5 Hepatotoxicants - an overview
  • Table 1.1 Hepatotoxicants and their mode of action
  • 1.2.6 Plants with hepatoprotective efficacy - a birds eye view
  • Table 1.2 Hepatoprotectant plants and their parts used
  • 1.2.7 A glimpse on hepatoprotectant herbal formulations
  • Table 1.3 Hepatoprotectant herbal formulations and their proven activities
  • 1.2.8 Other hepatoprotectants
  • 1.2.9 The plants under investigation
  • 1.2.9a Coscinium fenestratum
  • PLATE 1.2 (a) Coscinium fenestratum (b) Stem part of C. fenestratum
  • PLATE 1.3 (a) Curculigo orchiodes b. Rhizomes of C.orchioides
  • 1.2.9.b Curculigo orchioides
  • 1.2.10 About the thesis
  • 2. Materials and Methods
  • 2.1 Plant materials
  • 2.1a Coscinium fenestratum
  • 2.1b Curculigo orchioides
  • 2.2 Experimental animals
  • 2.3 Chemicals
  • 2.4 Instruments used
  • 2.5 Experimental design
  • 2.5.1 Induction of hepatopathy
  • 2.5.2 Preliminary evaluation of anti-hepatotoxic effect of extracts of
  • 2.5.3 Preliminary evaluation of anti-hepatotoxic effect of extracts of
  • 2.5.4 Hepatoprotective effect of C. fenestratum - a dose dependentstudy with methanol extract
  • 2.5.5 Hepatoprotective effect of C orchioides - a dose dependentstudy with methanol extract
  • 2.5.6 Hepatoprotective efficacy of C. fenestratum - a detailed study.
  • 2.5.7 Hepatoprotective efficacy of C. orchioides -- a detailed study.
  • 2.5.8 Antioxidant effect of C. fenestratum
  • 2.5.9 Antioxidant effect of C. orchioides
  • 2.6 Collection of serum and tissue samples
  • 2.7 Biochemical tests
  • 2.8 Histopathology
  • 2.9 Statistical analysis
  • 2.10 Percentage of hepatoprotection.
  • 2.11 Procedure for biochemical tests
  • 3. Anti-hepatotoxic efficacy of Coscinium fenestratum and Curculigo orchioides
  • 3.1 Introduction
  • 3.2 Materials and Methods
  • 3.2.1 Plant materials
  • 3.2.2 Experimental animals
  • 3.2.3 Experimental design
  • 3.3 Results and discussion
  • 3.3.1 Food consumption and weight gain
  • 3.1 Mean food consumption (grams) per 100 gram body weight of ratsadministered C. fenestmtum
  • 3.2 Mean food consumption (grams) per 100 gram body weight of ratsadministered C. orclrioicles
  • 3.3 Effect of C. fenestrafum on body weight in rats
  • 3.4 Effect of C: orchioides on body weight in rats.
  • 3.3.2 Activities of liver marker enzymes
  • 3.5 Effect of C.fmestrotum extracts (75 mg / kg bw) on the activities of livermarker enzymes in the serum of rats
  • 3.6 Effect of C. orctrioih extracts (75 mg / kg bw) on the activities of liver marker enzymes
  • 3.7 Effect of different doses of MECF on the activities of liver marker enzymes
  • 3.8 Effect of different doses of MECO on the activities of liver marker enzymes
  • 3.9 Percentage of hepatoprotection offered by different doses of MECF
  • 3.10 Percentage of hepatoprotection offered by different doses of MECO
  • 3.33 Other biochemical constituents
  • 3.11 Effect of MECF on biochemical parameters in the serum of rats
  • 3.12 Effect of MECF on biuchemical parameters in the liver of rats
  • 3.13 Effect of MECF on biochemical parameters in the kidney of rats
  • 3.14 Effect of MECO on biochemical parameters in the serum of rats
  • 3.15 Effect of MECO on biochemical parameters in the liver of rats
  • 3.16 Effect of MECO on biochemical parameters in the kidney of rats
  • 3.17 Percentage hepatoprotection offered by MECF in respect of different biochemical constituents in the serum /liver/ kidney of rats
  • 3.18 Percentage hepatoprotection offered by MECO in respect of different biochemical constituents in serum / liver / kidney of rats
  • PLATE 3.1 Photomicrographs of liver sections of CC14- treated rat stained with Haematoxylin & Eosin (X 100)
  • PLATE 3.2 Photomicrographs of liver sections of rat stained with Haematoxylin & Eosin (X 100)
  • PLATE 3.3 Photomicrographs of liver sections of rat stained with Haematoxylin & Eosin (X 100)
  • 3.3.4 Histopathology
  • 4. Antioxidant activity of Coscinium fenestratum and Curculigo orchioides in carbon tetrachloride-induced hepatopathy in rats
  • 4.1 Introduction
  • 4.2 Materials and methods
  • 4.2.1 Plant materials
  • 4.2.2 Experimental animals
  • 4.2.3 Experimental design
  • 4.3 Results
  • 4.3.1 TEARS, CD and GSH contents
  • 4. I Effect of C. fenestratum on the antioxidant status of liver in rats
  • 4.2 Effect of C. feneshatum on the antioxidant status of kidney in rats
  • 4.3 Effect of C. orc11ioidr.s on the antioxidant status of liver in rats
  • 4.4 Effect of C. orchioides on the antioxidant status of kidney in rats
  • 4.3.2 Antioxidant enzymes
  • 4.5 Effect of MECF on the activities of antioxidant enzymes in the liver of rats
  • 4.6 Effect of MECF on the activities of antioxidant enzymes in the kidney of rats
  • 4.7 Effect of MECO on the activities of antioxidant enzymes in the liver of rats
  • 4.8 Effect of MECO on thc activities of antioxidant enzymes in the kidney ofrats
  • 4.3.3 Activities of LDH and G-6-PD
  • 4.9 Effect of MECF on the activities of LDH and G-6-PD
  • 4.10 Effect of MECO on the activities of LDH and G-6-PD
  • 4.4 Discussion
  • 5. Isolation, purification and characterization of hepatoprotective principle from Coscinium fenestratum
  • 5.1 Introduction
  • 5.2 Materials and methods
  • 5.3 Results and discussion
  • 5.3.1 Spectroscopic study
  • 5.3.2 Berberine
  • 5.3.3 Hepatoprotective and antioxidant activity of berberine from
  • 5.1 Effect of the purified compound from C.fenestratum on the activities of liver marker enzymes.
  • 5.2 Percentage of hepatoprotection offered by the purified sample in respect of marker enzymes
  • 5.3 Effect of the purified compound from C. fenestratum on the activities of antioxidant enzymes
  • 5.4 Percentage of hepatoprotection offered by the purified sample in respect of antioxidant enzymes
  • Fig. 5.1 IR spectrum of the purified compound
  • Fig. 5 2 Mass spectrum of the purified compound
  • Fig. 5.3 UV spectrum of the purified compound
  • Fig. 5.4 H NMR spectrum of the purified compound
  • Fig. 5.5
  • 6. General Discussion
  • Fig.6.1 Overall hepatoprotection by powdered Coscinium fenestraturn stem and Curculigo orchioides rhizomes.
  • Fig.6.2 Overall hepatoprotection by different extracts of C. fenestratum and C.orchioides
  • Fig.6.3 Percentage of hepatoprotection by different doses of MECF in respect of liver marker enzymes
  • Fig.6.4 Percentage of hepato protection by different doses of MECO in respect of liver marker enzymes
  • Fig.6.5 Overall hepatoprotection shown by MECF (60 mg / kg) and MECO (70 mg 1 kg) with respect to different biochemica! parameters in serum
  • Fig.6.6 Overall hepatoprotection shown by MECF (60 mg / kg) and MECO (70 rng / kg) with respect to different biochemical parameters in liver.
  • Fig.6.7 Overall hepatuprotection shown by MECF (60 mg / kg) and MECO (70 mg / kg) with respect to different biochemical parameters in kidney.
  • Fig.6.8 Overall hepatoprotection by MECF and MECO in respect of antioxidant parameters in the liver of rats.
  • Fig.6.9 Overall hepatoprotection by MECF and MECO in respect of antioxidant parameters in the kidney of rats.
  • Fig. 6.10 Percentage of hepatoprotection offered by MECF and MECO in respect of activities of G-6-PD (in liver) and LDH (in serum)
  • Fig.6.11 Percentage of hepatoprotection offered by the purified compound from C.fenestratum in respect of different parameters.
  • Significance and the future prospects
  • 7. Summary
  • References
  • List of Papers published / accepted for publication / communicated